Literature DB >> 4631230

Mutation of gonococci and meningococci in vitro to rifampin (rifampicin) resistance.

H Schneider, A S Dobek, M S Artenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4631230      PMCID： PMC1048375          DOI： 10.1136/sti.48.6.500

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN： 0007-134X


× No keyword cloud information.
  13 in total

1.  Prevalence of meningococcal serogroups and description of three new groups.

Authors:  J R Evans; M S Artenstein; D H Hunter
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

2.  A 'single dose' treatment of gonococcal urethritis with rifampicin.

Authors:  V L Ongom
Journal:  Br J Vener Dis       Date:  1971-06

3.  Rifampin: effect of two-day treatment on the meningococcal carrier state and the relationship to the levels of drug in sera and saliva.

Authors:  L F Devine; D P Johnson; S L Rhode; C R Hagerman; W E Pierce; R O Peckinpaugh
Journal:  Am J Med Sci       Date:  1971-02       Impact factor: 2.378

4.  Effectiveness of rifampin in eradicating the meningococcal carrier state in a relatively closed population: emergence of resistant strains.

Authors:  C E Weidmer; T B Dunkel; F S Pettyjohn; C D Smith; A Leibovitz
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

5.  Rifampin: antibacterial activity in vitro and absorption and excretion in normal young men.

Authors:  P E Dans; R F McGehee; C Wilcox; M Finland
Journal:  Am J Med Sci       Date:  1970-02       Impact factor: 2.378

6.  Efficacy of rifampin in treatment of meningococcal carriers.

Authors:  W B Deal; E Sanders
Journal:  N Engl J Med       Date:  1969-09-18       Impact factor: 91.245

7.  Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.

Authors:  A Vall-Spinosa; W Lester; T Moulding; P T Davidson; J K McClatchy
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

8.  Effect of rifampin and minocycline on meningococcal carrier rates.

Authors:  R B Guttler; G W Counts; C K Avent; H N Beaty
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

9.  Rifampicin (Rimactane) in the treatment of gonorrhoea.

Authors:  R R Willcox; G D Morrison; R J Cobbold
Journal:  Br J Vener Dis       Date:  1970-04

10.  Rifadin (rifampicin) in the treatment of gonorrhoea in Uganda. A controlled trial.

Authors:  O P Arya; S K Rao; E Nnochiri
Journal:  Br J Vener Dis       Date:  1971-06
View more
  1 in total

1.  Mechanism of Rifampicin Inactivation in Nocardia farcinica.

Authors:  Heba Abdelwahab; Julia S Martin Del Campo; Yumin Dai; Camelia Adly; Sohby El-Sohaimy; Pablo Sobrado
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.